CNTX – context therapeutics inc. (US:NASDAQ)

News

Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at Wall Stre
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at Wall Stre
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
Context Therapeutics GAAP EPS of -$0.10 misses by $0.01 [Seeking Alpha]
Context Therapeutics (NASDAQ:CNTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com